__CANCER_TYPE__
___TRIAL_ID_/_ACRONYNM
PATIENT FRENDILY TITLE
This trial is open to patient enrollment as of February 9, 2022. The official study record from the National Cancer Institute website will be coming soon.
The ECOG-ACRIN Cancer Research Group designed this trial and is conducting it with funding from the National Cancer Institute through its National Clinical Trials Network.
